Clinical Trials

Blogs

CAR-T Cell Therapy: How an Emerging Treatment is Providing Hope for Mesothelioma Patients

Clinical Trials in Inflammatory Diseases: From Organ-Targeted to Mechanism of Action-Targeted Therapies
Life Science News

“Count Me In” Program Offers Cancer Patients the Chance to Share Health Data and Contribute to Research

How to Develop a Global Clinical Study Budget Like a Pro
Blogs

Managing the Screen Failure Rate in NASH Clinical Trials: The Use of Cytokeratin 18 Assays as a Prescreening Tool
Clinical Trial News

Are Clinical Trials Really That Costly? These Researchers Say They Don’t Have to Be

Are You Spending Too Much on Risk-Based Monitoring?

Interventional vs. Non-Interventional: Considerations for Correctly Classifying Your Clinical Study

Renal Trials in the Asia Pacific: Where Are We & What Does the Future Hold?

Sponsor-Facilitated Relationships Between Late Stage Researchers and Phase 1 Sites: A Novel Model for Early Phase Studies

Demystifying IRT Terminology

Biomarkers in NASH Drug Development: Using Cytokeratin 18 as a Secondary Endpoint in Clinical Trials

Getting the Most Out of Interactive Response Technology in Clinical Trial Supply

Patient Recruitment Strategies: New Methods for Scale-Up and Eliminating Redundancies

Digital Health: Optimizing Clinical Trials with Patient-Centric Technology